Hrt Financial LP Harrow Health, Inc. Transaction History

Hrt Financial LP

$15.6 Billion
Q1 2024

A detailed history of Hrt Financial LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 19,400 shares of HROW stock, worth $405,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,400

Holding current value

$405,266

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$9.3 - $13.23 $180,420 - $256,662	19,400 New	19,400 $256,000
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $825,182 - $1.28 Million	59,623 Added 133.92%	104,146 $2.2 Million
Q4 2022 Feb 10, 2023	BUY	$10.28 - $14.78 $457,696 - $658,049	44,523 New	44,523 $657,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $482,570 - $681,276	-56,773 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $36,075 - $54,706	-5,161 Reduced 8.33%	56,773 $516,000

Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $413,719 - $685,609	61,934 New	61,934 $575,000
Q3 2020 Nov 13, 2020	SELL	$4.71 - $7.36 $167,110 - $261,132	-35,480 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.61 - $6.47 $76,607 - $137,299	21,221 Added 148.83%	35,480 $184,000
Q1 2020 May 15, 2020	BUY	$3.5 - $7.31 $49,906 - $104,233	14,259 New	14,259 $54,000

Others Institutions Holding HROW

# of Institutions

123

Shares Held

21.3M

Call Options Held

113K

Put Options Held

366K

Opaleye Management Inc. Boston, MA

3.92M
Shares

$81.9 Million
12.62% of portfolio
Private Capital Management, LLC Naples, FL

3.01M
Shares

$62.9 Million
4.93% of portfolio
Black Rock Inc. New York, NY

2.18M
Shares

$45.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.83M
Shares

$38.2 Million
0.0% of portfolio
Morgan Stanley New York, NY

953K
Shares

$19.9 Million
0.0% of portfolio

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $565M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account